4-AcO-DiPT |
| 4-AcO-DiPT | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemical Nomenclature | |||||||||||||||||||||||||
| Common names | 4-Acetoxy-DiPT, ipracetin, 4-AcO-DiPT | ||||||||||||||||||||||||
| Substitutive name | 4-acetoxy-N,N-diisopropyltryptamine | ||||||||||||||||||||||||
| Systematic name | 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-yl acetate | ||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||
| Psychoactive class | Psychedelic | ||||||||||||||||||||||||
| Chemical class | Tryptamine | ||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| Summary sheet: 4-AcO-DiPT |
4-Acetoxy-DiPT (4-acetoxy-N,N-diisopropyltryptamine, ipracetin, 4-AcO-DiPT) is a hallucinogenic psychedelic drug of the tryptamine family.
It is described online as being similar to psilocin combined with 2C-B and has a uniquely short duration of 2 - 4 hours. It is around as potent as 4-HO-DiPT with an active dose reported at between 15 and 40 mg.[1]
Contents
Chemistry
4-AcO-DiPT, or 4-acetoxy-N,N-diisopropyltryptamine, is a synthetic indole alkaloid molecule of the tryptamine class. Tryptamines share a core structure comprised of a bicylic indole heterocycle attached at R3 to an amino group via an ethyl side chain. 4-AcO-DiPT is substituted at R4 of its indole heterocycle with an acetoxy (AcO) functional group CH3COO−. It also contains two (di) isopropyl chains bound to the terminal amine RN of its tryptamine backbone (DiPT).
4-AcO-DiPT is the N-substituted isopropyl homologue of 4-HO-DMT (Psilocin). 4-AcO-DiPT is the acetate ester analogue of DiPT and the N-substituted diisopropyl analogue of 4-AcO-DMT.[2]
Pharmacology
4-AcO-DiPT likely acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from 4-AcO-DiPT's efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
It is worth noting that 4-AcO-DiPT is reported to feel identical to its 4-HO-DiPT counterpart.[1] This is in the same manner that 4-AcO-DMT/4-HO-DMT, 4-AcO-MET/4-HO-MET, and 4-AcO-DET/4-HO-DMT all feel subjectively identical to their counterpart, suggesting that 4-AcO compounds are deacetylated into 4-HO compounds.
Subjective effects
| |
This subjective effect breakdown is a stub. As such, it may contain incomplete or wrong information and is still in progress. You can help by expanding it. |
The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.
Physical effects
- Bodily control enhancement
- Increased heart rate
- Nausea
- Pupil dilation
- Spontaneous tactile sensations
- Tactile enhancement
Cognitive effects
- Analysis enhancement
- Conceptual thinking
- Creativity enhancement
- Delusions
- Emotion enhancement
- Immersion enhancement
- Memory suppression
- Mindfulness
- Novelty enhancement
- Personal bias suppression
- Spirituality enhancement
- Thought acceleration
- Thought disorganization
- Thought loops
- Time distortion
- Unity and interconnectedness
- Wakefulness
Visual effects
Enhancements
Distortions
- Drifting (melting, breathing, morphing and flowing)
- Colour shifting
- Depth perception distortions
- Perspective distortions
- Symmetrical texture repetition
- Tracers
Geometry
Hallucinatory states
- Transformations
- Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots)
Auditory effects
Toxicity and harm potential
| |
The toxicity and long-term health effects of recreational 4-AcO-DiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 4-AcO-DiPT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 4-AcO-DiPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
It is strongly recommended that one use harm reduction practices when using this drug.
Tolerance and addiction potential
4-AcO-DiPT is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.
Tolerance to the effects of 4-AcO-DiPT are built almost immediately after ingestion. Afterwards, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 4-AcO-DiPT presents cross-tolerance with all psychedelics, meaning that after the consumption of 4-AcO-DiPT all psychedelics will have a reduced effect.
Legal issues
- United Kingdom - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[3]
- Denmark - 4-AcO-DiPT is a Schedule B controlled substance in Denmark.[4]
- Japan - 4-Acetoxy-DiPT is a controlled substance in Japan.[5]
- Sweden - 4-AcO-DiPT is illegal to sell or possess in Sweden.[6]
- United States - 4-Acetoxy-DiPT is an unscheduled substance in the United States. Due to similarities to other scheduled tryptamines such as psilocin and 5-MeO-DiPT, possession may be prosecuted under the Federal Analog Act in the United States.
See also
External links
References
- ↑ 1.0 1.1 4-acetoxy-DiPT Primer (Erowid) | https://www.erowid.org/chemicals/4_acetoxy_dipt/4_acetoxy_dipt_primer.shtml
- ↑ 4-Acetoxy-DiPT - PubChem | https://pubchem.ncbi.nlm.nih.gov/compound/24801868
- ↑ Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted
- ↑ https://www.retsinformation.dk/Forms/R0710.aspx?id=137169
- ↑ ホーム > 政策について > 分野別の政策一覧 > 健康・医療 > 医薬品・医療機器 > 薬物乱用防止に関する情報 | http://www.mhlw.go.jp/bunya/iyakuhin/yakubuturanyou/scheduled-drug/list.html
- ↑ Svensk författningssamling | http://www.notisum.se/rnp/sls/sfs/20050026.pdf